Mice exposed to these interventions showed reduced microglial activation and a decline in pro-inflammatory cytokine levels, highlighting the ability of β2-AR signaling to mitigate harmful neuroinflammatory responses that exacerbate AD pathology [53]. The gene discussed is ADRB2; the disease is Alzheimer disease.